As you quoted "On June 9, 2022, Innovation Pharmaceuticals Inc. (the “Company”) entered into a Series A Preferred Share Purchase Agreement (the “Purchase Agreement”) with Squalus Med Ltd., a company established under the laws of the State of Israel (“SML”), pursuant to which the Company purchased 55,556 shares of SML’s Series A Redeemable Preferred Shares (the “Series A Shares”)"....
....and it is those shares that are now useless to IPIX. They can't sell them, lend them or use them as security. Hence they are currently worthless to IPIX.

Shareholders of the Company need to know that.

"IPIX put that asset up security, but continues to own their interest in BeaMed. It is worth far more in future earnings than 1.4M."
They lost their case and as a result were REQUIRED to post the only asset they had that could act as security for the judgment. It is now USELESS to them. Do you really expect them to win their appeal? Do you know what happens if/when they don't?

In 2020 a poster noted that Leo/IPIX was stiffing Menon and Cummings. You said ""Stiffing" these individuals carries the accusation that Leo NEVER INTENDS TO PAY THEM. We are well aware of these liabilities. But without evidence that they will never be paid, it's BULLSH-T."
I guess it's too soon to call it never, but it is 4 years+ later and both parties remain stiffed.

Wrong for 8 years and counting:
"Incredible prospects for a super cheap stock! I am adding."
(your first post)

"Then why was the BeaMed stake mentioned in the latest Cummings vs Innovation Pharmaceutical court case?"
If you read that mention carefully you would have noticed that it said that the BeaMed stake is now acting as Cummings' security for the $1.4M judgment against IPIX. IPIX can't do anything at all with those shares. That's why it was mentioned.
Accordingly it's fair to say that there’s every reason to believe IPIX no longer has any stake in BeaMed, even if you and the 9 people who liked your post would rather not accept that.
IPIX's stake in BeaMed is worth less to IPIX than your stake in IPIX is worth to you.

"The catalyst will likely be the first product with Brilacidin that IPIX gets a FDA nod for after a successful Phase 3. "
There are no Phase 3s under way nor is the Company in a position to undertake any.

"IPIX is currently in a holding pattern because its finances are dependent on its investment in BeaMed."
Cummings has been granted an equitable lien and continuing security interest in IPIX's investment in BeaMed. IPIX's investment in BeaMed is worthless to IPIX at the moment per the Order of Postjudgment Security in Case no. 2077CV00101.

"08/23/2024 ORDER: of Post Judgment Security
..II. ALTERNATIVE SECURITY
In accordance with General Laws c. 223, sec. 86A, Innovation shall obtain and provide within thirty (30) days of this Order a bond payment to Cummings with sureties to be approved by this Court conditioned to pay Cummings the amount of at least $1,375,811.36, within thirty (30) days of the date when execution may issue upon judgment, which bond shall be filed with the clerk after its approval by the Court. "

Most recent appeals case (2024-P-0638) activity:
11/12/2024 #18 Appellee brief filed for Cummings Properties, LLC by Attorney Michael Barker.
11/26/2024 #19 Motion of Appellant to extend date for filing Reply Brief filed for Innovation Pharmaceuticals Inc. by Attorney Daniel Dwyer.
11/26/2024 RE#19: Allowed to 1/19/25. *Notice.

No mention has been made in either docket of the provision of the bond to Cummings. I think it's obvious that IPIX couldn't fund it.

You said this: "You propose a company can use and sell Brilacidin and pay Ipix nothing?"
Your implication was clearly that IPIX must have been compensated when other companies used and/or sold brilacidin (small b).

So again I ask:
Please explain why IPIX has never recorded any revenue at all related to those uses.
Either they didn't receive any revenue or they failed to record it. Pick one.

"I was suggesting merger with already established Nasdaq company with cash looking for assets".

Is that really what you meant by this?
"Maybe they just get funding deal and go straight to Nasdaq??"

What assets? I wasn't unclear. I said that THE SHARES that you hold essentially are not marketable.

"Maybe they just get funding deal and go straight to Nasdaq??"
Have you read the NASDAQ listing standards? It wouldn't seem so....RSPI doesn't come close to meeting any of them.
https://listingcenter.nasdaq.com/assets/initialguide.pdf

It says a lot that you actually believe that this board has been read 75,000 times in the last 24 hours. But that's a different issue than the one that was being discussed.....the breakout board IS NOT based on reads. Do I need to explain it again?

Your shit ton of due diligence has resulted in your holding of shares that essentially are not marketable.

Position on the BOB is based on "the change in posting activity in the past 24 hours vs. the average from the prior 7 days", not the number of board reads.
On a board like this just a few posters can have a big influence on a BOB position. For example you and 2 other posters account for more than half of the most recent poster activity, making up the majority of what you refer to as "so much interest in this EM stock".

Tell him all of it. The Break out board measures posting activity and has zero to do with the Company's operations.

"You propose a company can use and sell Brilacidin and pay Ipix nothing?"
Please explain why IPIX has never recorded any revenue at all related to those uses. Obviously I'm referring to uses during the period prior to IPIX's decision to cease providing public information altogether.

You can't have it both ways. Either they didn't receive any revenue or they failed to record it.
My money is on the former but I'd like to hear your opinion.

The CEO of OTCMarkets provided an update to that March of 2021 article in September of 2023:
https://blog.otcmarkets.com/2023/09/14/the-expert-market-its-larger-role-post-rule-15c2-11/

It's simple really:
OTC Markets Group operates the Expert Market.
Quotations in Expert Market securities are restricted from public viewing.
Only broker-dealers and professional or sophisticated investors are permitted to view quotations in Expert Market securities.
(above per OTCMarkets)

Bid 0.00
Ask 0.00
https://ih.advfn.com/stock-market/USOTC/respirerx-pharmaceuticals-ce-RSPI/stock-price
https://www.otcmarkets.com/stock/RSPI/quote


You can buy or sell RSPI shares if you can find a broker willing to take the trade and are willing to do so without a quote.
I believe the B/A numbers you are seeing here are actually based on the latest trading activity and not actual offers to buy and sell.

jmo

There isn't any bid and ask lol
That's the effect of being on the Expert Market.

Volume: 3

2 weeks later: "i'm happy w/ my investment."
What changed that?

Painful.

"Big Z, we have no idea what he's doing behind the scenes"
Sure we do....he's out helping OJ find the real killers.

"...and there is concern that RSPI is starved for money? Hmmmm... I don't think so."

That's what their last financial statement says: Cash and cash equivalents $6,362

And that's what their Chief Financial Officer says: "Getting current with our SEC filings is one of several top priorities. The SEC filings cannot be done until our auditors are independent. We owe them enough that they are not currently independent."

I guess I'm missing your point. You asked "Maybe some accredited are accumulating?"
My post was intended to ask whether you actually thought that accredited investors, as defined, engaged in trading in the piddling amounts that were traded on Friday. I don't believe they do.

https://www.law.cornell.edu/cfr/text/17/230.501

If and when actual accredited/sophisticated investors ever evidence any interest in RSPI it will be obvious, a lot more obvious than $1,900 worth of trading suggests.

How many accredited investors do you think it might take to execute less than $2,000 in trading? Woohooo?

10/28/2024 10/28/2024 20244426902 Amended and Restated Articles Internal 15

Common 370000000.00000000 .001
Preferred 32000000.00000000 .001
https://esos.nv.gov/EntitySearch/BusinessFilingHistoryOnline
-----------------------------------------------------------------------------------------------------------------------------------------

Convertible series A preferred stock, $0.001 par value, no shares authorized,
no shares issued and outstanding - -
Convertible series B preferred stock, $0.001 par value, 30,000,000 shares
authorized, 20,878,000 and 21,483,000 shares issued and outstanding at September
30, 2024 and December 31, 2023, respectively 20,878 21,483
Series E preferred stock, $0.001 par value, 1,000,000 shares authorized,
1,000,000 shares issued and outstanding

https://www.otcmarkets.com/otcapi/company/financial-report/417801/content


Looks like they authorized another 1 million preferred shares per that 10/28 Nevada filing.
Were they issued? To whom? For what? On what terms and what are the rights and preferences conveyed by the shares?


Bueller?

1. "ResolutionRx and the OSA program is already spun out"
2. "I am curious whether that company eventually is listed for trading and RSPI distributes shares to current shareholders."

1 is technically not true unless and until 2 occurs. ("Or will RSPI be more like a holding company?").

I still have mine!

Nonsense. Bought and paid for nonsense:
"SCD Media LLC (d/b/a “Smallcaps Daily”), hereinafter referred to as “Smallcaps Daily,” and their affiliates and control persons (the “Publisher”) are in the business of publishing favorable information and/or advertisements (the “Information”) about the securities of publicly traded companies (each an “Issuer” or collectively the “Issuers”) in exchange for compensation (the “Campaigns”)."
https://profiles.smallcapsdaily.com/nnvc/

IPIX has until 1/19 to respond to the Cummings brief filed on 11/12.
Unfortunately we don't get to see what these briefs say.

This is the last hard fact I've seen...from the original case:
"08/23/2024 ORDER: of Post Judgment Security
..II. ALTERNATIVE SECURITY
In accordance with General Laws c. 223, sec. 86A, Innovation shall obtain and provide within thirty (30) days of this Order a bond payment to Cummings with sureties to be approved by this Court conditioned to pay Cummings the amount of at least $1,375,811.36, within thirty (30) days of the date when execution may issue upon judgment, which bond shall be filed with the clerk after its approval by the Court."

Would be interesting to know if that was done....I thought the appeal was contingent on it.

A real humdinger:
https://ih.advfn.com/stock-market/AMEX/nanoviricides-NNVC/chart/streaming

"$NNVC is gaining momentum—watch closely for exciting market moves! 📈"

Click on the 3 month chart on the right. It looks like the little thing that you posted only yours is upside down.
Momentum my ass.

It's not "news" and a PR was issued:
https://www.sec.gov/ix?doc=/Archives/edgar/data/849636/000149315224021733/form8-k.htm

"drawing attention and forcing shorts to cover"
One more time.....THERE ARE NO SHORTS IN RSPI and there haven't been any since July.

To have a short squeeze one must first have shorts to squeeze.

"he's due to update his shareholders....."

What a ridiculous comment. Due? He's been OBLIGATED to update his shareholders (and everyone else) since the 10Q that was filed A YEAR AGO yesterday and he hasn't.
He continues to show himself to be irresponsible at the very least....crooked is probably more fitting.

You're lucky you haven't heard from him. It would only add fuel to your misguided beliefs.

Lots of ink. Lots of zeroes after the decimal point in the Company share price. An absent-without-explanation CEO. And no Current Information.

How does entry into the Expert Market fit with the just-like-Regeneron-does-it strategy?

I'll bet the Regeneron shareholders could find their CEO if they needed to.

How's the Regeneron ray gun program going?

10Q due today!

Or it would be due if they had filed the two 10Qs and the 10K that they failed to file previously.

Just an FYI....the Cummings response to the IPIX appeal is due today.

And if I remember correctly no connection could be made between the 2 Ehrlichs. Tried again yesterday with the same result. For that matter the Locust Walk and IPIX relationship came up empty as well.

Definitely not his son.....read this:
https://www.kellogg.northwestern.edu/news_articles/profiles/alumni/chris-ehrlich.aspx

This guy's dad died 5-6 years ago.

I know little of the science involved. I do know that investors value currently recruiting clinical trials (Phase 2 to provide Phase 3 dosing) in the US more highly than trials in Australia promised by a Company that has no history of success in such things.
That said, I wonder if you can provide some detail to the "huge amounts of funding" you believe that Company has raised. I see an S-3 registration covering the sale of shares by SHAREHOLDERS and a discounted debenture issued with discounted warrants. requiring a second S-3.

What were you referring to when you spoke of huge amounts of funding?
Even given the lagging development effort of RSPI relative to Incannex I wouldn't be surprised if this Company couldn't find a toxic lender or two who might find such terms appealing if RSPI ws to offer them.

"additional human clinicals"? I don't know the history of this Company as well as you do. Can you tell me about any clinical trials they've conducted?

"Just look at Incannex and the amount of money they have been raising for their dronabinol version for OSA."

Started recruiting at 5 US locations for Phase 2 trial to determine dosing for Phase 3.
Trades on NASDAQ. 17M shares outstanding. Zero debt as of last filing.

Look at Incannex, by all means:
https://www.sec.gov/edgar/browse/?CIK=1873875&owner=exclude
https://www.incannex.com/development-overview-2/